LAMP1 (Lysosome-Associated Membrane Protein 1) is a major lysosomal membrane protein that plays a critical role in lysosomal function, autophagy, and cellular proteostasis. As part of the LAMP family, LAMP1 forms a protective glycocalyx on the lysosomal inner membrane and facilitates autophagosome-lysosome fusion—processes critically impaired in neurodegenerative diseases including Alzheimer's disease and Parkinson's disease[1].
| Property | Value |
|---|---|
| Protein Name | LAMP1 |
| Gene Symbol | LAMP1 |
| UniProt ID | P13473 |
| Chromosomal Location | 13q34 |
| Protein Family | LAMP family |
| Location | Lysosomal/endosomal membrane |
| Molecular Weight | ~120 kDa (heavy glycosylation) |
LAMP1 is a type I transmembrane glycoprotein with three distinct domains[2]:
LAMP1 forms a dense glycocalyx that [3]:
LAMP1 is essential for autophagosome-lysosome fusion through its interaction with LC3 (microtubule-associated protein 1A/1B-light chain 3) and other autophagy proteins [4]:
LAMP1 plays a role in TFEB (Transcription Factor EB) activation[5]:
LAMP1 participates in cellular cholesterol homeostasis through interaction with NPC1 (Niemann-Pick C1 protein)[6]:
LAMP1 and LAMP2 are closely related paralogs with both overlapping and distinct functions[7]:
| Feature | LAMP1 | LAMP2 |
|---|---|---|
| Gene | LAMP1 (13q34) | LAMP2 (Xq24) |
| Protein Size | ~120 kDa | ~110 kDa |
| Expression | Ubiquitous, highest in brain | Ubiquitous, highest in heart/liver |
| Autophagy Role | Autophagosome-lysosome fusion | Chaperone-mediated autophagy |
| Disease Association | AD, PD | Danon disease (LAMP2 mutations) |
| Knockout Phenotype | Viable, mild accumulation | Severe cardiomyopathy |
Dysregulation of LAMP1 is strongly implicated in Alzheimer's disease[8]:
Therapeutic implications:
In Parkinson's disease, LAMP1 is involved in[9]:
| Approach | Mechanism | Status |
|---|---|---|
| TFEB activators (rapamycin, trehalose) | Upregulate LAMP1 expression | Preclinical/clinical |
| Gene therapy (AAV-LAMP1) | Enhance LAMP1 delivery to neurons | Research |
| Autophagy enhancers | Boost overall lysosomal function | Investigational |
| Small molecule lysosomal boosters | Enhance lysosomal biogenesis | Early clinical |
Eskelinen EL, et al. (2004) "Role of LAMP proteins in lysosomal function and autophagy." Traffic. Traffic. 2004. ↩︎
Fukuda M (1991) "Lysosomal membrane glycoproteins. Structure, biosynthesis, and functions." Journal of Biochemistry. Journal of Biochemistry. 1991. ↩︎
Eskelinen EL (2006) "Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy." Molecular Aspects of Medicine. Molecular Aspects of Medicine. 2006. ↩︎
Hu YB, et al. (2015) "LAMP1 and the autophagy-lysosome pathway." Autophagy. Autophagy. 2015. ↩︎
Settembre C, et al. (2013) "TFEB links autophagy to lysosomal biogenesis." Science. Science. 2013. ↩︎
Infante RE, et al. (2008) "NPC2 facilitates cholesterol transfer from late endosomes to the lysosome." Journal of Biological Chemistry. Journal of Biological Chemistry. 2008. ↩︎
Konecki DS, et al. (1995) "The organization of the human LAMP1 and LAMP2 genes." Genomics. Genomics. 1995. ↩︎
Nixon RA, et al. (2005) "Autophagy in Alzheimer's disease." Nature Reviews Neuroscience. Nature Reviews Neuroscience. 2005. ↩︎
Gan-Or Z, et al. (2015) "LAMP1 and Parkinson's disease susceptibility." Brain. Brain. 2015. ↩︎